Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$43.82 - $85.37 $267,302 - $520,757
-6,100 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$33.21 - $51.27 $202,581 - $312,747
6,100 New
6,100 $263,000
Q1 2020

May 15, 2020

SELL
$20.56 - $63.12 $705,208 - $2.17 Million
-34,300 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$28.14 - $73.01 $965,202 - $2.5 Million
34,300 New
34,300 $2.18 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.46B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.